We are live on ! Find out more
GFM

GF Fund Management Portfolio holdings

AUM $5.98B
1-Year Est. Return 80.99%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+80.99%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.62B
AUM Growth
Cap. Flow
+$4.56B
Cap. Flow %
98.7%
Top 10 Hldgs %
48.03%
Holding
637
New
637
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$400M
2
AAPL icon
Apple
AAPL
+$352M
3
MSFT icon
Microsoft
MSFT
+$326M
4
AMZN icon
Amazon
AMZN
+$218M
5
META icon
Meta Platforms (Facebook)
META
+$195M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 45.41%
2 Consumer Discretionary 17.29%
3 Communication Services 14.35%
4 Healthcare 6.6%
5 Consumer Staples 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TEM
326
Tempus AI
TEM
$7.48B
$108K ﹤0.01%
+3,200
New +$158K
RHP icon
327
Ryman Hospitality Properties
RHP
$8.56B
$108K ﹤0.01%
+1,034
New +$115K
NUVL
328
DELISTED
Nuvalent
NUVL
$108K ﹤0.01%
+1,378
New +$129K
COLD icon
329
Americold
COLD
$4.21B
$105K ﹤0.01%
+4,905
New +$119K
TRNO icon
330
Terreno Realty
TRNO
$7.58B
$104K ﹤0.01%
+1,761
New +$109K
KRG icon
331
Kite Realty
KRG
$5.86B
$101K ﹤0.01%
+3,992
New +$105K
EPRT icon
332
Essential Properties Realty Trust
EPRT
$6.92B
$99.7K ﹤0.01%
+3,186
New +$104K
CRNX icon
333
Crinetics Pharmaceuticals
CRNX
$8.88B
$99.5K ﹤0.01%
+1,947
New +$109K
ALKS icon
334
Alkermes
ALKS
$8.11B
$97.7K ﹤0.01%
+3,397
New +$97.7K
KRYS icon
335
Krystal Biotech
KRYS
$10.7B
$94.6K ﹤0.01%
+604
New +$107K
MAC icon
336
Macerich
MAC
$7.4B
$90K ﹤0.01%
+4,516
New +$88.2K
ACLX
337
DELISTED
Arcellx
ACLX
$87K ﹤0.01%
+1,135
New +$98.1K
AXSM icon
338
Axsome Therapeutics
AXSM
$11.7B
$86.1K ﹤0.01%
+1,018
New +$93.6K
ADMA icon
339
ADMA Biologics
ADMA
$2.02B
$85.1K ﹤0.01%
+4,964
New +$93.4K
SRRK icon
340
Scholar Rock
SRRK
$5.88B
$85K ﹤0.01%
+1,966
New +$64K
CUZ icon
341
Cousins Properties
CUZ
$5.31B
$84.7K ﹤0.01%
+2,765
New +$84.8K
PECO icon
342
Phillips Edison & Co
PECO
$5.5B
$83.4K ﹤0.01%
+2,226
New +$84.8K
APLS
343
DELISTED
Apellis Pharmaceuticals
APLS
$83.3K ﹤0.01%
+2,612
New +$78.5K
IRT icon
344
Independence Realty Trust
IRT
$3.98B
$83.3K ﹤0.01%
+4,198
New +$85.7K
PM icon
345
Philip Morris
PM
$309B
$82.9K ﹤0.01%
+689
New +$86.9K
KRC icon
346
Kilroy Realty
KRC
$4.59B
$82K ﹤0.01%
+2,026
New +$81.8K
RARE icon
347
Ultragenyx Pharmaceutical
RARE
$2.46B
$81.6K ﹤0.01%
+1,939
New +$96.2K
SLG icon
348
SL Green Realty
SLG
$3.83B
$80K ﹤0.01%
+1,178
New +$87.1K
GH icon
349
Guardant Health
GH
$19.1B
$79.2K ﹤0.01%
+2,594
New +$73K
AHR icon
350
American Healthcare REIT
AHR
$11.1B
$78.4K ﹤0.01%
+2,758
New +$74.2K

Similar funds

GF Fund Management's Q4 2024 Portfolio in Review

Q4 2024 is the first quarter with a 13F filing on record for GF Fund Management, which disclosed 637 positions worth $4.62B. Its ten largest holdings account for 48% of the portfolio.

Its largest position is NVIDIA: 2,904,119 shares worth $390M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, followed by Consumer Discretionary and Communication Services.

  • GF Fund Management's largest Q4 2024 buy was NVIDIA: 2,904,119 shares worth $390M.
  • GF Fund Management's ten largest holdings make up 48% of its $4.62B portfolio in Q4 2024.
  • GF Fund Management disclosed 637 positions in Q4 2024, its first 13F filing on record.

Based on GF Fund Management's 13F filing for Q4 2024, filed 19 Feb 2025.